Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Baldini

Showing results (91-100 of 151) with videos related to

Pageof 16
Sort By:
Haematologica|November 21, 2007
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL studyMassimo Federico, Cesare Guglielmi, Stefano Luminari, et al.
Haematologica|July 13, 2014
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapiesSimona Caltagirone, Marina Ruggeri, Simona Aschero, et al.
British Journal of Haematology|January 14, 2004
Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer ResearchFrancesco Bertoni, Annarita Conconi, Sergio B Cogliatti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significanceFrancesca Rossi, Maria Teresa Petrucci, Andrea Guffanti, et al.
Leukemia & Lymphoma|March 23, 2013
Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana LinfomiFrancesco Merli, Stefano Luminari, Giuseppe Rossi, et al.
Hematological Oncology|November 20, 2012
Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapySilvia Mappa, Emerenziana Marturano, Giada Licata, et al.
Critical Reviews in Oncology/Hematology|July 2, 2011
Primary plasma cell leukemia in the era of new drugs: has something changed?Pellegrino Musto, Livio Pagano, Maria Teresa Petrucci, et al.
Non-Coding RNA|March 19, 2020
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical OutcomeDomenica Ronchetti, Vanessa Favasuli, Paola Monti, et al.
Frontiers in Immunology|May 31, 2022
Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic PatientsBruno Fattizzo, Marta Bortolotti, Nicolò Rampi, et al.
Blood Advances|April 7, 2022
MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohortMatteo Claudio Da Vià, Marta Lionetti, Alessio Marella, et al.
Pageof 16

Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
Haematologica|November 21, 2007
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL studyMassimo Federico, Cesare Guglielmi, Stefano Luminari, et al.
Haematologica|July 13, 2014
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapiesSimona Caltagirone, Marina Ruggeri, Simona Aschero, et al.
British Journal of Haematology|January 14, 2004
Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer ResearchFrancesco Bertoni, Annarita Conconi, Sergio B Cogliatti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significanceFrancesca Rossi, Maria Teresa Petrucci, Andrea Guffanti, et al.
Leukemia & Lymphoma|March 23, 2013
Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana LinfomiFrancesco Merli, Stefano Luminari, Giuseppe Rossi, et al.
Hematological Oncology|November 20, 2012
Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapySilvia Mappa, Emerenziana Marturano, Giada Licata, et al.
Critical Reviews in Oncology/Hematology|July 2, 2011
Primary plasma cell leukemia in the era of new drugs: has something changed?Pellegrino Musto, Livio Pagano, Maria Teresa Petrucci, et al.
Non-Coding RNA|March 19, 2020
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical OutcomeDomenica Ronchetti, Vanessa Favasuli, Paola Monti, et al.
Frontiers in Immunology|May 31, 2022
Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic PatientsBruno Fattizzo, Marta Bortolotti, Nicolò Rampi, et al.
Blood Advances|April 7, 2022
MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohortMatteo Claudio Da Vià, Marta Lionetti, Alessio Marella, et al.
Pageof 16